AstraZeneca vaccine's chief investigator backs India's 12-16 week Covishield dose gap - Silver Screen

AstraZeneca vaccine's chief investigator backs India's 12-16 week Covishield dose gap

Share This
AstraZeneca vaccine's chief investigator backs India's 12-16 week Covishield dose gap

from India Today | Top Stories https://ift.tt/3wGClJ1

No comments: